Search research articles
Contact Us
Filters
Showing results (51-60 of 288) with videos related to
Page
of 29
Sort By:
Antiviral Therapy
|
August 24, 2007
DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions
Gracíela Andrei, Pierre Fiten, Matheus Froeyen, et al.
European Cytokine Network
|
October 18, 2011
Langerhans cell histiocytosis: a cytokine/chemokine-mediated disorder?
Lara Garabedian, Sofie Struyf, Ghislain Opdenakker, et al.
Nature Methods
|
February 28, 2013
Zymography methods for visualizing hydrolytic enzymes
Jennifer Vandooren, Nathalie Geurts, Erik Martens, et al.
Trends in Immunology
|
January 28, 2003
Neutralizing antibodies in gene-defective hosts
Ghislain Opdenakker, Philippe E Van den Steen, Geneviève Laureys, et al.
The American Journal of Pathology
|
February 11, 2015
Matrix metalloproteinase-9 is essential for physiological Beta cell function and islet vascularization in adult mice
Gustaf Christoffersson, Tomas Waldén, Monica Sandberg, et al.
European Journal of Immunology
|
September 5, 2002
Gelatinase B deficiency protects against endotoxin shock
Bénédicte Dubois, Sofie Starckx, Axel Pagenstecher, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 6, 2003
Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan
Peter H Larsen, Jennifer E Wells, William B Stallcup, et al.
Trends in Parasitology
|
October 14, 2019
Critical Roles of Endogenous Glucocorticoids for Disease Tolerance in Malaria
Leen Vandermosten, Ilse Vanhorebeek, Karolien De Bosscher, et al.
The Journal of Infectious Diseases
|
January 15, 2013
Heterogeneity and evolution of thymidine kinase and DNA polymerase mutants of herpes simplex virus type 1: implications for antiviral therapy
Graciela Andrei, Aspasia Georgala, Dimitri Topalis, et al.
Journal of Neurology
|
September 25, 2003
Serum gelatinase B/MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta-1a
Bénédicte Dubois, Siobhan M Leary, Inge Nelissen, et al.
Page
of 29
Search research articles
Search
Showing results (51-60 of 288) with videos related to
Sort By:
Page
of 29
Antiviral Therapy
|
August 24, 2007
DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions
Gracíela Andrei, Pierre Fiten, Matheus Froeyen, et al.
European Cytokine Network
|
October 18, 2011
Langerhans cell histiocytosis: a cytokine/chemokine-mediated disorder?
Lara Garabedian, Sofie Struyf, Ghislain Opdenakker, et al.
Nature Methods
|
February 28, 2013
Zymography methods for visualizing hydrolytic enzymes
Jennifer Vandooren, Nathalie Geurts, Erik Martens, et al.
Trends in Immunology
|
January 28, 2003
Neutralizing antibodies in gene-defective hosts
Ghislain Opdenakker, Philippe E Van den Steen, Geneviève Laureys, et al.
The American Journal of Pathology
|
February 11, 2015
Matrix metalloproteinase-9 is essential for physiological Beta cell function and islet vascularization in adult mice
Gustaf Christoffersson, Tomas Waldén, Monica Sandberg, et al.
European Journal of Immunology
|
September 5, 2002
Gelatinase B deficiency protects against endotoxin shock
Bénédicte Dubois, Sofie Starckx, Axel Pagenstecher, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 6, 2003
Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan
Peter H Larsen, Jennifer E Wells, William B Stallcup, et al.
Trends in Parasitology
|
October 14, 2019
Critical Roles of Endogenous Glucocorticoids for Disease Tolerance in Malaria
Leen Vandermosten, Ilse Vanhorebeek, Karolien De Bosscher, et al.
The Journal of Infectious Diseases
|
January 15, 2013
Heterogeneity and evolution of thymidine kinase and DNA polymerase mutants of herpes simplex virus type 1: implications for antiviral therapy
Graciela Andrei, Aspasia Georgala, Dimitri Topalis, et al.
Journal of Neurology
|
September 25, 2003
Serum gelatinase B/MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta-1a
Bénédicte Dubois, Siobhan M Leary, Inge Nelissen, et al.
Page
of 29